Should Faster Rapid-Acting Insulins be the standard for first line therapy?
Eli Lilly and Company |
Monday
Coming soon… 2 October 2023 17:00 – 18:00 CEST Warsaw Hall
Coming soon… 2 October 2023 17:00 – 18:00 CEST Warsaw Hall
Chair: Brit’ney Grimes (USA) 12:00 – 12:15 Welcome and Introduction of Tirzepatide 12:15 – 12:30 Review of SURPASS-2 12:30 – 12:45 Indirect Comparison of Tirzepatide
Coming soon… 3 October 2023 07:45 – 08:45 CEST Sofia Hall
12:00 – 12:30 Addressing Weight Management in People with Type 2 Diabetes 3 October 2023 12:00 – 12:30 CEST Spotlight Stage
Coming soon… 4 October 2023 17:00 – 17:30 CEST Spotlight Stage
